Investing.com -- Genenta Science (NASDAQ:GNTA) stock soared 241.8% in premarket trading Friday after announcing a strategic collaboration with ANEMOCYTE focused on off-the-shelf lentiviral vector ...
MILAN - Genenta Science (NASDAQ:GNTA), a clinical-stage biotech company with a market capitalization of $61.84 million, and Anemocyte announced Friday a strategic collaboration focused on ...
A verdict of medical misadventure has been returned after an inquest heard recommended liver function tests were not carried out on a woman to monitor the effects of a drug that ultimately led to her ...
A University of Alberta research team has uncovered a new role for a genetic mutation previously known to be linked to developmental disorders—and it could hold the key to more effective treatments ...
When most people think about side hustles, they picture selling vintage clothes online or ride share, crafting something and selling it on Etsy or Amazon. But for 23-year-old Avalon Saph, known to her ...
But for 23-year-old Avalon Saph, known to her fans as Lana, her most lucrative gig comes from something far less conventional: selling videos of herself farting. “I’ve been paid like 200 bucks to send ...
CHICAGO--(BUSINESS WIRE)--#BioTechNews--VectorBuilder, a global leader in gene delivery technologies and CDMO services, today announced the publication of the miniVec plasmid system, engineered for ...
PARIS, Oct 4 (Reuters) - French carmaker Renault (RENA.PA), opens new tab plans to cut 3,000 jobs through a voluntary redundancy offer for staff in support functions, French newsletter L'Informe ...
MILTON -- It’s a bake-off. It’s a grilling competition. It’s a bags-tournament. It’s all of that and more. It’s Junction Function. Hosted by the Milton Area Chamber of Commerce, the event will be held ...
This guide provides an in-depth exploration of the essential role plasmids play in biotechnology and genetic engineering. From foundational concepts to the complexities of high-throughput production, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results